-+ 0.00%
-+ 0.00%
-+ 0.00%

Bausch Health FY26 Q1 net loss widens to $1.42 billion; revenue rises 12% to $2.52 billion

PUBT·04/29/2026 20:27:18
Listen to the news
Bausch Health FY26 Q1 net loss widens to $1.42 billion; revenue rises 12% to $2.52 billion
  • Bausch Health posted a Q1 2026 net loss attributable to shareholders of USD 1.42 billion, driven by a USD 1.43 billion goodwill impairment charge.
  • Revenue climbed 12% to USD 2.52 billion.
  • Adjusted EBITDA attributable to shareholders rose 27% to USD 837 million.
  • Salix segment revenue jumped 18% to USD 639 million, with Xifaxan revenue up 21%.
  • Full-year 2026 guidance calls for revenue of USD 10.67 billion-USD 10.92 billion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch Health Companies Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202604291605PR_NEWS_USPR_____NY46151) on April 29, 2026, and is solely responsible for the information contained therein.